logo dark logo light logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
logo dark logo light logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
Mobile Logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
Image Alt
News & Media

Phoenix

Nov 8
Phoenix
Events

PHOENIX @ CIBER-BBN Annual Conference

“PHOENIX – Pharmaceutical OITB for Enabling Nano-pharmaceutical Innovative Products” will be presented by Nazende Günday-Türeli, MyBiotech GmbH, at the CIBER-BBN Annual Conference on the 16th November at 15:00.

see event
Like

Related Posts

Apr 10
Phoenix

PHOENIX SEP Rising: Redefining the Nanopharmaceutical Journey from Bench to Bedside

Read More
Jan 20
Phoenix

PHOENIX Booth at Enhanced Sustainability in Pharma

Read More
Dec 4
Phoenix

PHOENIX Partners at PODD in Boston

Read More

Post Categories

  • Events
  • News
  • Newsletter
  • Project Outcomes

Recent News

  • Updated Service Portfolio Now Available! September 12, 2025
  • Polymer-based imaging agent: Interview with Prof. Mangala Srinivas September 5, 2025
  • Advanced Nanoparticle Characterization Technologies from RECENDT August 25, 2025

Tags

AdMa ANTHOS24 call characterization CMC computer simulation customers European Researchers’ Night 2023 Fabry Fabry Disease GLA interview in vitro manufacturing MRI nanomedicine nanoparticles nanopharmaceuticals nanotechnology OITB pharmaceuticals physchem podcast quality-by-design quality control rare diseases Regulatory advice Regulatory Support services SSbD sustainability Training video webinar

Contact us

MyBiotech GmbH
Industriestraße 1B
66802 Überherrn
Germany
info@phoenix-oitb.eu

Join the PHOENIX community!

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 953110.

 

Downloads  |  Legal Notice  |  Privacy Policy